Cargando…

Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers

Recently, targeted nanoparticles (NPs) have attracted much attention in cancer treatment due to their high potential as carriers for drug delivery. In this article, we present a novel bioconjugate (DOX–AuNPs–Tmab) consisting of gold nanoparticles (AuNPs, 30 nm) attached to chemotherapeutic agent dox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Żelechowska-Matysiak, Kinga, Wawrowicz, Kamil, Wierzbicki, Mateusz, Budlewski, Tadeusz, Bilewicz, Aleksander, Majkowska-Pilip, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058186/ https://www.ncbi.nlm.nih.gov/pubmed/36985421 http://dx.doi.org/10.3390/molecules28062451

Ejemplares similares

Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles
por: Żelechowska-Matysiak, Kinga, et al.
Publicado: (2023)

Au@(109)Pd core–shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of (109)Pd/(109m)Ag in vivo generator in combined β(−) auger electron therapy
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2023)

Platinum nanoparticles labelled with iodine-125 for combined “chemo-Auger electron” therapy of hepatocellular carcinoma
por: Wawrowicz, Kamil, et al.
Publicado: (2023)

Nanoparticles in Targeted Alpha Therapy
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2020)

Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma
por: Wawrowicz, Kamil, et al.
Publicado: (2022)

Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with (44)Sc and (47)Sc for Theranostic Application
por: Ünak, Perihan, et al.
Publicado: (2023)

Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of (193m)Pt and (195m)Pt Radionuclides in Auger Electron Therapy
por: Wawrowicz, Kamil, et al.
Publicado: (2021)

Lipidic Cubic-Phase Nanoparticles (Cubosomes) Loaded with Doxorubicin and Labeled with (177)Lu as a Potential Tool for Combined Chemo and Internal Radiotherapy for Cancers
por: Cytryniak, Adrianna, et al.
Publicado: (2020)

Trastuzumab-Modified Gold Nanoparticles Labeled with (211)At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer
por: Dziawer, Łucja, et al.
Publicado: (2019)

Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter (213)Bi
por: Cytryniak, Adrianna, et al.
Publicado: (2022)

Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin
por: Nieciecka, Dorota, et al.
Publicado: (2021)

(198)Au-Coated Superparamagnetic Iron Oxide Nanoparticles for Dual Magnetic Hyperthermia and Radionuclide Therapy of Hepatocellular Carcinoma
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2023)

Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment
por: Żuk, Michał, et al.
Publicado: (2022)

Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy
por: Żuk, Michał, et al.
Publicado: (2021)

1,2-Benzenedithiol and Toluene-3,4-dithiol Arsenic(III) Complexes—Synthesis, Structure, Spectroscopic Characterization and Toxicological Studies
por: Lyczko, Monika, et al.
Publicado: (2019)

Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy
por: Gawęda, Weronika, et al.
Publicado: (2020)

Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with (99m)Tc and (177)Lu as Potential Receptor Radiopharmaceuticals
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2018)

Effect of Surface Functionalization on the Cellular Uptake and Toxicity of Nanozeolite A
por: Męczyńska-Wielgosz, Sylwia, et al.
Publicado: (2016)

Design and Evaluation of (223)Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy–Part I
por: Czerwińska, Malwina, et al.
Publicado: (2020)

Functionalized TiO(2) nanoparticles labelled with (225)Ac for targeted alpha radionuclide therapy
por: Cędrowska, Edyta, et al.
Publicado: (2018)

Nanostructures as Radionuclide Carriers in Auger Electron Therapy
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2022)

Lanthanide-Doped SPIONs Bioconjugation with Trastuzumab for Potential Multimodal Anticancer Activity and Magnetic Hyperthermia
por: Gawęda, Weronika, et al.
Publicado: (2020)

Synthesis, characterization, and interactions of single-walled carbon nanotubes modified with doxorubicin with Langmuir–Blodgett biomimetic membranes
por: Matyszewska, Dorota, et al.
Publicado: (2018)

The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2019)

Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab
por: Yousefpour, Parisa, et al.
Publicado: (2011)

Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum]
Publicado: (2022)

Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with (225)Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer
por: Cędrowska, Edyta, et al.
Publicado: (2020)

Photothermal therapeutic application of gold nanorods-porphyrin-trastuzumab complexes in HER2-positive breast cancer
por: Kang, Xinmei, et al.
Publicado: (2017)

Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
por: You, Yiwen, et al.
Publicado: (2018)

Corrections to “Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer”
por: Baselga, J., et al.
Publicado: (2019)

Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer
por: Rocca, Andrea, et al.
Publicado: (2021)

Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer
por: Nunes, Toni, et al.
Publicado: (2019)

Corrigendum: Photothermal therapeutic application of gold nanorods-porphyrin-trastuzumab complexes in HER2-positive breast cancer
por: Kang, Xinmei, et al.
Publicado: (2017)

Effect of Trastuzumab–HER2 Complex Formation on Stress-Induced Modifications in the CDRs of Trastuzumab
por: Spanov, Baubek, et al.
Publicado: (2022)

Cyclotron production of (43)Sc for PET imaging
por: Walczak, Rafał, et al.
Publicado: (2015)

Multimodal Gold Nanostars as SERS Tags for Optically-Driven Doxorubicin Release Study in Cancer Cells
por: Minati, Luca, et al.
Publicado: (2021)

Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
por: Gorini, Stefania, et al.
Publicado: (2018)

Doxorubicin‐induced and trastuzumab‐induced cardiotoxicity in mice is not prevented by metoprolol
por: Nicol, Martin, et al.
Publicado: (2021)

HER2 therapy: Molecular mechanisms of trastuzumab resistance
por: Nahta, Rita, et al.
Publicado: (2006)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_oiqjkf6uujpmd3p14vpeppu933